lOMoAR $fd cPSD|l3O0M13o8A0R4cPSD| $fd 3013804
TEST BANK
$fd
Advanced Practice Nursing in the Care of Older
$fd $fd $fd $fd $fd $fd $fd
Adults by Laurie Kennedy-Malone
$fd $fd $fd $fd
Second Edition.
$fd
TEST BANK $fd
, lOMoAR
Advanced Practice Nursing in the Care of
$fd cPSD|
$fd 3013804
$fd $fd $fd $fd $fd $fd
Older Adults / Edition 2 TESTBANK
$fd $fd $fd $fd $fd $fd
Chapter 1. Changes With Aging
$fd $fd $fd $fd
Multiple $fdChoice
Identify $fdthe $fdchoice $fdthat $fdbest $fdcompletes $fdthe $fdstatement $fdor $fdanswers $fdthe $fdquestion.
1. The $fdmajor $fdimpact $fdof $fdthe $fdphysiological $fdchanges $fdthat $fdoccur $fdwith $fdaging $fdis:
A. Reduced $fdphysiological $fdreserve
B. Reduced $fdhomeostatic $fdmechanisms
C. Impaired $fdimmunological $fdresponse
D. All $fdof $fd the $fdabove
2. The $fdstrongest $fdevidence $fdregarding $fdnormal $fdphysiological $fdaging $fdis $fdavailable
$fd through:
A. Randomized $fdcontrolled $fdclinical $fdtrials
B. Cross-sectional $fdstudies
C. Longitudinal $fdstudies
D. Case $fdcontrol $fdstudies
3. All $fdof $fdthe $fdfollowing $fdstatements $fdare $fdtrue $fdabout $fdlaboratory $fdvalues $fdin $fdolder
adults $fdexcept:
$fd
A.
Reference $fdranges $fdare $fdpreferable
B.
Abnormal $fdfindings $fdare $fdoften $fddue $fdto $fdphysiological $fdaging
C.
Normal $fdranges $fdmay $fdnot $fdbe $fdapplicable $fdfor $fdolder $ f d adults
D.
Reference $fdvalues $fdare $fdnot $fdnecessarily $fdacceptable $fdvalues
4. Biochemical $fdindividuality $fdis $fdbest $fddescribed $fdas:
A. Each $fdindividual’s $fdvariation $fdis $fdoften $fdmuch $fdgreater $fdthan $fdthat $fdof $fda $fdlarger
$fdgroup
B. The $fdunique $fdbiochemical $fdprofile $fdof $fda $fdselected $fdpopulation
C. The $fdtruly $fd“normal” $fdindividual—falling $fdwithin $fdaverage $fdrange
D. Each $fdindividual’s $fdvariation $fdis $fdoften $fdmuch $fdsmaller $fdthan $fdthat $fdof $fda $fdlarger
$fdgroup
5. Polypharmacy $fdis $fdbest $fddescribed $fdas $fdtaking:
A. More $fdthan $fdnine $fdmedications $fdper $fd day
B. More $fdthan $fdfive $fdmedications $fdper $fd day
C. Even $fda $fdsingle $fdmedication $fdif $fdthere $fdis $fdnot $fda $fdclear $fdindication $fdfor $fdits $ f d use
D. When $fda $fddrug $fdis $fdgiven $fdto $fdtreat $fdthe $fdside $fdeffect $fdof $fdanother $ fd drug
6. Pharmacokinetic $fdchanges $fdwith $fdaging $fdis $fdreflective $fdof:
A. What $fdthe $fddrug $fddoes $fdto $fdthe $fdbody
B. What $fdthe $fdbody $fddoes $fdto $fdthe $fddrug
C. The $fdeffect $fdat $fdthe $fdsite $fdof $fdaction $fdand $fdthe $fdtime $fdand $fdintensity $fdof $fd the $fddrug
, lOMoAR
$fd cPSD|
$fd 3013804
D. $fdThe $fdside $fdeffects $fdcommonly $fdassociated $fdwith $fdthe $fddrug
$f d 7. $fdAll $fdthe $fdfollowing $fdstatements $fdare $fdfalse $fdabout $fddrug $fdabsorption $ f d except:
$ fd
A. Antacids $fdincrease $fdthe $fdbioavailability $fdof $fddigitalis
B. Gastric $fdacidity $fddecreases $fdwith $fdage
C. Anticholinergics $fdincrease $fdcolonic $fd motility
D. Underlying $fdchronic $fddisease $fdhas $fdlittle $fdimpact $fdon $fddrug $f d absorption
$f d 8. $fdAll $fdof $ f d the $fdfollowing $fdstatements $fdare $fdtrue $fdabout $fddrug $fddistribution $fdin $fdthe $fdelderly $fdexcept:
$ fd
A. Drugs $fddistributed $fdin $fdwater $fdhave $fdlower $ f d concentration
B. Drugs $fddistributed $fdin $fdfat $fdhave $fdless $fdintense, $fdmore $fdprolonged $ f d effect
C. Drugs $fdhighly $fdprotein $fdbound $fdhave $fdgreater $fdpotential $fdto $fdcause $fdan
adversedrug $fdreaction
$fd
D. The $fdfastest $fdway $fdto $fddeliver $fda $fddrug $fdto $fdthe $fdaction $fdsite $fdis $fdby $fdinhalation
$f d $ fd 9. $fdMen $fdhave $fdfaster $fdand $fdmore $fdefficient $fdbiotransformation $fdof $fddrugs $fdand $fdthis $fdis $fdthought $fdto $fdbe
$fd due $ f d to:
A. Less $fdobesity $fdrates $fdthan $fdwomen
B. Prostate $fdenlargement
C. Testosterone
D. Less $fdestrogen $fdthan $fdwomen
$fd 10. $fdThe $fdcytochrome $fdp $fdsystem $fdinvolves $fdenzymes $fdthat $fdare $ f d generally:
A. Inhibited $fdby $fddrugs
B. Induced $fdby $fddrugs
C. Inhibited $fdor $fdinduced $fdby $fddrugs
D. Associated $fdwith $fddecreased $fdliver $fd perfusion
$fd 11. $fdA $fdstatement $fdnot $fdshown $fdto $fdbe $fdtrue $fdabout $fdpharmacodynamics $fdchanges $fdwith $fdaging $ f d is:
A. Decreased $fdsensitivity $fdto $fdoral $fdanticoagulants
B. Enhanced $fdsensitivity $fdto $fdcentral $fdnervous $fdsystem $fddrugs
C. Drug $fdresponsiveness $fdcan $fdbe $fdinfluenced $fdby $fdpatient $fdactivity $fd level
D. There $fdis $fda $fddecreased $fdsensitivity $fdto $fdbeta $f d blockers
$fd 12. $fdAtypical $fdpresentation $fdof $fddisease $fdin $fdthe $fdelderly $fdis $fdreflected $fdby $fdall $fdthe $fdfollowing $fd except:
A. Infection $fdwithout $fdfever
B. Depression $fdwithout $fddysphoric $fd mood
C. Myocardial $fdinfarction $fdwith $fdchest $fdpain $fdand $fddiaphoresis
D. Cardiac $fdmanifestations $fdof $fdthyroid $fddisease
$fd 13. $fdFunctional $fdabilities $fdare $fdbest $fdassessed $ f d by:
A. Self-report $fdof $fdfunction
B. Observed $fdassessment $fdof $fdfunction
C. A $fdcomprehensive $fdhead-to-toe $fdexamination
D. Family $fdreport $fdof $fdfunction
, lOMoAR
$fd cPSD|
$fd 3013804
Chapter 1: Changes with Aging
$fd $fd $fd $fd
Answer Section
$fd $fd
MULTIPLE $fdCHOICE
1. $fdANS: D PTS: 1
2. $fdANS: C PTS: 1
3. $fdANS: B PTS: 1
4. $fdANS: D PTS: 1
5. $fdANS: C PTS: 1
6. $fdANS: B PTS: 1
7. $fdANS: D PTS: 1
8. $fdANS: A PTS: 1
9. $fdANS: C PTS: 1
10. $fdANS: C PTS: 1
11. $fdANS: A PTS: 1
12. $fdANS: C PTS: 1
13. $fdANS: B PTS: 1
Chapter 2. HealthPromotion
$fd $fd
Multiple $fdChoice
Identify $fdthe $fdchoice $fdthat $fdbest $fdcompletes $fdthe $fdstatement $fdor $fdanswers $fdthe $fdquestion.
$f d $ fd 1. $fdThe $fdleading $fdcause $fdof $fddeath $fdin $fdelderly $fdtravelers $fdworldwide $ f d is:
A. Cardiovascular $fddisease
B. Infections
C. Accidents
D. Malaria
$ f d 2. $fdWhich $fdof $fdthe $fdfollowing $fdshould $fdbe $fdavoided $fdin $fdcountries $fdwhere $fdfood $fdand $fdwater
precautions $fdare $fdto $fdbe $fdobserved?
$fd
A. Hot $fdcoffee
B. Bottled $fdwater
C. Salad $fd buffet
D. Unpeeled $fdbananas
$f d $ fd 3. $fdWhat $fdinsect $fdprecautions $fdare $fdnot $fdnecessary $fdto $fdprevent $fdinsect-borne $fddiseases $fdin $fdthe $ f d tropic
A. Using $fd100% $fdDEET $fdon $fdskin $fdto $fdprevent $fd bites
B. Treating $fdclothes $fdwith $fdpermetherin
C. Covering $fdup $fdexposed $fdskin $fdto $fdlessen $fdbiting $fdsurface
D. Taking $fdmalaria $fdpills $fdas $fddirected $fdfor $fdareas $fdat $fdrisk $fdfor $ f d malaria
TEST BANK
$fd
Advanced Practice Nursing in the Care of Older
$fd $fd $fd $fd $fd $fd $fd
Adults by Laurie Kennedy-Malone
$fd $fd $fd $fd
Second Edition.
$fd
TEST BANK $fd
, lOMoAR
Advanced Practice Nursing in the Care of
$fd cPSD|
$fd 3013804
$fd $fd $fd $fd $fd $fd
Older Adults / Edition 2 TESTBANK
$fd $fd $fd $fd $fd $fd
Chapter 1. Changes With Aging
$fd $fd $fd $fd
Multiple $fdChoice
Identify $fdthe $fdchoice $fdthat $fdbest $fdcompletes $fdthe $fdstatement $fdor $fdanswers $fdthe $fdquestion.
1. The $fdmajor $fdimpact $fdof $fdthe $fdphysiological $fdchanges $fdthat $fdoccur $fdwith $fdaging $fdis:
A. Reduced $fdphysiological $fdreserve
B. Reduced $fdhomeostatic $fdmechanisms
C. Impaired $fdimmunological $fdresponse
D. All $fdof $fd the $fdabove
2. The $fdstrongest $fdevidence $fdregarding $fdnormal $fdphysiological $fdaging $fdis $fdavailable
$fd through:
A. Randomized $fdcontrolled $fdclinical $fdtrials
B. Cross-sectional $fdstudies
C. Longitudinal $fdstudies
D. Case $fdcontrol $fdstudies
3. All $fdof $fdthe $fdfollowing $fdstatements $fdare $fdtrue $fdabout $fdlaboratory $fdvalues $fdin $fdolder
adults $fdexcept:
$fd
A.
Reference $fdranges $fdare $fdpreferable
B.
Abnormal $fdfindings $fdare $fdoften $fddue $fdto $fdphysiological $fdaging
C.
Normal $fdranges $fdmay $fdnot $fdbe $fdapplicable $fdfor $fdolder $ f d adults
D.
Reference $fdvalues $fdare $fdnot $fdnecessarily $fdacceptable $fdvalues
4. Biochemical $fdindividuality $fdis $fdbest $fddescribed $fdas:
A. Each $fdindividual’s $fdvariation $fdis $fdoften $fdmuch $fdgreater $fdthan $fdthat $fdof $fda $fdlarger
$fdgroup
B. The $fdunique $fdbiochemical $fdprofile $fdof $fda $fdselected $fdpopulation
C. The $fdtruly $fd“normal” $fdindividual—falling $fdwithin $fdaverage $fdrange
D. Each $fdindividual’s $fdvariation $fdis $fdoften $fdmuch $fdsmaller $fdthan $fdthat $fdof $fda $fdlarger
$fdgroup
5. Polypharmacy $fdis $fdbest $fddescribed $fdas $fdtaking:
A. More $fdthan $fdnine $fdmedications $fdper $fd day
B. More $fdthan $fdfive $fdmedications $fdper $fd day
C. Even $fda $fdsingle $fdmedication $fdif $fdthere $fdis $fdnot $fda $fdclear $fdindication $fdfor $fdits $ f d use
D. When $fda $fddrug $fdis $fdgiven $fdto $fdtreat $fdthe $fdside $fdeffect $fdof $fdanother $ fd drug
6. Pharmacokinetic $fdchanges $fdwith $fdaging $fdis $fdreflective $fdof:
A. What $fdthe $fddrug $fddoes $fdto $fdthe $fdbody
B. What $fdthe $fdbody $fddoes $fdto $fdthe $fddrug
C. The $fdeffect $fdat $fdthe $fdsite $fdof $fdaction $fdand $fdthe $fdtime $fdand $fdintensity $fdof $fd the $fddrug
, lOMoAR
$fd cPSD|
$fd 3013804
D. $fdThe $fdside $fdeffects $fdcommonly $fdassociated $fdwith $fdthe $fddrug
$f d 7. $fdAll $fdthe $fdfollowing $fdstatements $fdare $fdfalse $fdabout $fddrug $fdabsorption $ f d except:
$ fd
A. Antacids $fdincrease $fdthe $fdbioavailability $fdof $fddigitalis
B. Gastric $fdacidity $fddecreases $fdwith $fdage
C. Anticholinergics $fdincrease $fdcolonic $fd motility
D. Underlying $fdchronic $fddisease $fdhas $fdlittle $fdimpact $fdon $fddrug $f d absorption
$f d 8. $fdAll $fdof $ f d the $fdfollowing $fdstatements $fdare $fdtrue $fdabout $fddrug $fddistribution $fdin $fdthe $fdelderly $fdexcept:
$ fd
A. Drugs $fddistributed $fdin $fdwater $fdhave $fdlower $ f d concentration
B. Drugs $fddistributed $fdin $fdfat $fdhave $fdless $fdintense, $fdmore $fdprolonged $ f d effect
C. Drugs $fdhighly $fdprotein $fdbound $fdhave $fdgreater $fdpotential $fdto $fdcause $fdan
adversedrug $fdreaction
$fd
D. The $fdfastest $fdway $fdto $fddeliver $fda $fddrug $fdto $fdthe $fdaction $fdsite $fdis $fdby $fdinhalation
$f d $ fd 9. $fdMen $fdhave $fdfaster $fdand $fdmore $fdefficient $fdbiotransformation $fdof $fddrugs $fdand $fdthis $fdis $fdthought $fdto $fdbe
$fd due $ f d to:
A. Less $fdobesity $fdrates $fdthan $fdwomen
B. Prostate $fdenlargement
C. Testosterone
D. Less $fdestrogen $fdthan $fdwomen
$fd 10. $fdThe $fdcytochrome $fdp $fdsystem $fdinvolves $fdenzymes $fdthat $fdare $ f d generally:
A. Inhibited $fdby $fddrugs
B. Induced $fdby $fddrugs
C. Inhibited $fdor $fdinduced $fdby $fddrugs
D. Associated $fdwith $fddecreased $fdliver $fd perfusion
$fd 11. $fdA $fdstatement $fdnot $fdshown $fdto $fdbe $fdtrue $fdabout $fdpharmacodynamics $fdchanges $fdwith $fdaging $ f d is:
A. Decreased $fdsensitivity $fdto $fdoral $fdanticoagulants
B. Enhanced $fdsensitivity $fdto $fdcentral $fdnervous $fdsystem $fddrugs
C. Drug $fdresponsiveness $fdcan $fdbe $fdinfluenced $fdby $fdpatient $fdactivity $fd level
D. There $fdis $fda $fddecreased $fdsensitivity $fdto $fdbeta $f d blockers
$fd 12. $fdAtypical $fdpresentation $fdof $fddisease $fdin $fdthe $fdelderly $fdis $fdreflected $fdby $fdall $fdthe $fdfollowing $fd except:
A. Infection $fdwithout $fdfever
B. Depression $fdwithout $fddysphoric $fd mood
C. Myocardial $fdinfarction $fdwith $fdchest $fdpain $fdand $fddiaphoresis
D. Cardiac $fdmanifestations $fdof $fdthyroid $fddisease
$fd 13. $fdFunctional $fdabilities $fdare $fdbest $fdassessed $ f d by:
A. Self-report $fdof $fdfunction
B. Observed $fdassessment $fdof $fdfunction
C. A $fdcomprehensive $fdhead-to-toe $fdexamination
D. Family $fdreport $fdof $fdfunction
, lOMoAR
$fd cPSD|
$fd 3013804
Chapter 1: Changes with Aging
$fd $fd $fd $fd
Answer Section
$fd $fd
MULTIPLE $fdCHOICE
1. $fdANS: D PTS: 1
2. $fdANS: C PTS: 1
3. $fdANS: B PTS: 1
4. $fdANS: D PTS: 1
5. $fdANS: C PTS: 1
6. $fdANS: B PTS: 1
7. $fdANS: D PTS: 1
8. $fdANS: A PTS: 1
9. $fdANS: C PTS: 1
10. $fdANS: C PTS: 1
11. $fdANS: A PTS: 1
12. $fdANS: C PTS: 1
13. $fdANS: B PTS: 1
Chapter 2. HealthPromotion
$fd $fd
Multiple $fdChoice
Identify $fdthe $fdchoice $fdthat $fdbest $fdcompletes $fdthe $fdstatement $fdor $fdanswers $fdthe $fdquestion.
$f d $ fd 1. $fdThe $fdleading $fdcause $fdof $fddeath $fdin $fdelderly $fdtravelers $fdworldwide $ f d is:
A. Cardiovascular $fddisease
B. Infections
C. Accidents
D. Malaria
$ f d 2. $fdWhich $fdof $fdthe $fdfollowing $fdshould $fdbe $fdavoided $fdin $fdcountries $fdwhere $fdfood $fdand $fdwater
precautions $fdare $fdto $fdbe $fdobserved?
$fd
A. Hot $fdcoffee
B. Bottled $fdwater
C. Salad $fd buffet
D. Unpeeled $fdbananas
$f d $ fd 3. $fdWhat $fdinsect $fdprecautions $fdare $fdnot $fdnecessary $fdto $fdprevent $fdinsect-borne $fddiseases $fdin $fdthe $ f d tropic
A. Using $fd100% $fdDEET $fdon $fdskin $fdto $fdprevent $fd bites
B. Treating $fdclothes $fdwith $fdpermetherin
C. Covering $fdup $fdexposed $fdskin $fdto $fdlessen $fdbiting $fdsurface
D. Taking $fdmalaria $fdpills $fdas $fddirected $fdfor $fdareas $fdat $fdrisk $fdfor $ f d malaria
